Green Lifescience Co., Ltd. (KOSDAQ: 114450)

Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,454	6,348	2,814	3,388	2,402	7,514
Short-Term Investments	2,000	3,669	2,300	7,800	7,800	10,032
Trading Asset Securities	2,280	4,436	11,835	5,015	4,930	2,961
Cash & Short-Term Investments	12,734	14,453	16,949	16,203	15,133	20,507
Cash Growth	-29.20%	-14.73%	4.60%	7.08%	-26.21%	-0.15%
Accounts Receivable	4,236	1,451	2,509	3,450	1,753	5,451
Other Receivables	36.23	8.54	333.75	114.13	284.56	123.38
Receivables	4,272	1,460	2,843	3,564	2,037	5,574
Inventory	4,569	5,311	6,014	5,732	6,649	4,892
Prepaid Expenses	-	160.15	42.62	735.77	438.83	595.21
Other Current Assets	195.76	328.73	595.04	657.55	314.22	93.81
Total Current Assets	21,770	21,712	26,443	26,892	24,572	31,662
Property, Plant & Equipment	13,073	13,256	27,112	36,846	35,626	35,079
Long-Term Investments	-	-	-	7,381	9,912	3,916
Other Intangible Assets	2.52	2.81	87.92	181.72	370.26	558.63
Long-Term Deferred Tax Assets	-	-	-	619.37	355.14	566.61
Long-Term Deferred Charges	16.9	24.91	-	-	-	102.34
Other Long-Term Assets	9,213	8,833	8,788	57.44	12.08	10
Total Assets	44,076	43,828	62,432	71,977	70,846	71,894
Accounts Payable	692.63	-	-	4,114	2,835	2,538
Accrued Expenses	107.91	-	-	2.12	136.07	180.91
Short-Term Debt	4,800	4,800	6,488	7,433	6,211	5,100
Current Portion of Leases	89.9	104.04	117.85	104.86	170.18	160.18
Current Unearned Revenue	34	34	34	-	-	-
Other Current Liabilities	1,159	2,455	2,796	3,588	1,429	3,093
Total Current Liabilities	6,884	7,394	9,437	15,242	10,781	11,072
Long-Term Leases	21.47	28.82	18.27	57.76	31.42	-
Other Long-Term Liabilities	7.23	8.12	6.78	8.19	6.67	8.98
Total Liabilities	7,373	7,874	9,793	15,679	11,475	11,537
Common Stock	10,000	10,000	7,500	7,500	7,500	7,500
Additional Paid-In Capital	15,025	36,425	38,956	38,956	38,956	38,956
Retained Earnings	13,701	-10,105	6,232	9,680	12,820	13,892
Treasury Stock	-2,023	-366.29	-	-	-	-
Comprensive Income & Other	-0	0	-48.7	162.39	95.97	9.77
Shareholders' Equity	36,703	35,954	52,639	56,298	59,371	60,358
Total Liabilities & Equity	44,076	43,828	62,432	71,977	70,846	71,894
Total Debt	4,911	4,933	6,624	7,595	6,413	5,260
Net Cash (Debt)	7,823	9,520	10,324	8,608	8,720	15,247
Net Cash Growth	-18.38%	-7.79%	19.93%	-1.28%	-42.81%	-1.23%
Net Cash Per Share	397.14	476.93	515.40	430.30	438.28	765.05
Filing Date Shares Outstanding	19.09	19.83	20	20	20	20
Total Common Shares Outstanding	19.09	19.83	20	20	20	20
Working Capital	14,887	14,319	17,007	11,651	13,791	20,590
Book Value Per Share	1922.87	1812.66	2631.95	2814.92	2968.56	3017.88
Tangible Book Value	36,700	35,951	52,551	56,117	59,001	59,799
Tangible Book Value Per Share	1922.74	1812.52	2627.55	2805.83	2950.04	2989.95
Land	8,425	8,425	8,329	7,923	7,923	7,923
Buildings	7,846	7,846	16,077	13,381	13,381	13,309
Machinery	35,479	35,434	38,766	39,913	37,596	37,364
Construction In Progress	83.9	23.1	207.03	11,769	10,758	8,395

Source: S&P Capital IQ. Standard template. Financial Sources.